MétaCan
Menu
Back to cohort
Record W4392593498 · doi:10.1016/j.drudis.2024.103948

Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development

2024· article· en· W4392593498 on OpenAlexfundno aff
Elena Peeva, Anindita Banerjee, Christopher Banfield, Koshika Soma, Jared Christensen, Sandeep Menon, Michael S. Vincent, Mikael Dolsten

Bibliographic record

VenueDrug Discovery Today · 2024
Typearticle
Languageen
FieldMedicine
TopicHidradenitis Suppurativa and Treatments
Canadian institutionsnot available
FundersCMC MicrosystemsPfizer
KeywordsDrug developmentPharmaceutical sciencesInflammationClinical trialMedicineDrug discoveryDrugClinical immunologyImmunologyComputational biologyPharmacologyBioinformaticsBiologyInternal medicineAllergy

Abstract

fetched live from OpenAlex

Master protocol designs, such as umbrella and basket studies, allow multiple compounds or multiple target populations to be evaluated simultaneously within a single protocol, and have been widely adopted in oncology clinical trials. These novel designs can also be applied in other therapeutic areas, where they could have several benefits over conducting traditional randomized controlled trials. Here, we detail Pfizer's recent implementations of master protocol designs in inflammation and immunology clinical studies, focusing on the opportunities for cost and resource savings and how these designs can expedite the time required to bring new treatments to patients in need.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.154
metaresearch head score (Gemma)0.158
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.846
Threshold uncertainty score0.812

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1540.158
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0020.001
Science and technology studies0.0010.003
Scholarly communication0.0050.007
Open science0.0030.005
Research integrity0.0020.006
Insufficient payload (model declined to judge)0.0260.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.073
GPT teacher head0.378
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designTheoretical or conceptual
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2024
Admission routes1
Has abstractno

Explore more

Same venueDrug Discovery TodaySame topicHidradenitis Suppurativa and TreatmentsFrench-language works237,207